Prevalence and Clinical Significance of Potential Drug–Drug Interactions in Hospitalized Pediatric Oncology Patients: A Prospective Pharmacoepidemiologic Study
This is the first prospective study from Iran-and the largest in the region-investigating PDDIs in pediatric oncology. The dual-database screening approach improved PDDI detection. Clinical teams should routinely evaluate medication profiles in pediatric cancer patients to minimize avoidable harms from DDIs.
Authors
- Alekhya Lavu (ORCID: https://orcid.org/0000-0003-3198-6020)
- Payam Peymani (ORCID: https://orcid.org/0000-0002-7223-8590)
- Sherif Eltonsy (ORCID: https://orcid.org/0000-0002-0520-5406)
- Omid Reza Zekavat (ORCID: https://orcid.org/0000-0002-0008-3198)
- Mohammadamin Sadeghdoust (ORCID: https://orcid.org/0000-0001-5055-1618)
- Mohammadreza Bordbar (ORCID: https://orcid.org/0000-0002-8071-6425)
- Narjes Zarsanj
Institutions
- Shiraz University of Medical Sciences (IR)
- Namazi Hospital (IR)
- University of Manitoba (CA)
Publication Details
- Journal
- Cancers
- Published
- 2025-09-18
- DOI
- https://doi.org/10.3390/cancers17183054
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shiraz University of Medical Sciences
- Shiraz University